Browse 16+ health diagonstics startup programs and investors. Find the right program for your startup journey.
A network accelerator programme for the most innovative life science startups
Refactor Capital is an early-stage venture capital firm that invests in founders solving fundamental human problems.
Firefly Innovations, the premier public health entrepreneurship platform of CUNY SPH, hosts the annual CUNY Public Health Innovation Accelerator (the “Accelerator”). Sponsored by KPMG, focuses on health equity, digital health, and the social determinants of health. The Accelerator will supports at least eight ventures per year across all sectors working to solve public health challenges across the world.
We are trusted allies to founders solving our nation’s most critical problems.Our focus: Enterprise Software. Cyber Security. National Security. Based right outside Washington D.C. we are enterprise technology investors first and foremost. We work to support key initiatives of early-stage businesses.
Bulldog Innovation Group (BIG) is a Yale alumni venture fund investing in Yale alum-led companies. Our mission is to create value by investing time knowledge and capital in the Yale entrepreneurial community.
At Teamworthy Ventures we seek to develop long-term relationships with talented and trustworthy entrepreneurs and teams and we invest in their ventures at the seed early or growth stage. A sample of our investments: SeatGeek Ibotta Boxed and more. Our partners are Thomas Lehrman Evan Kaye and Stephen Schmalhofer. We are based in New York City.
Lifecycle Venturing
BRIDGING OPPORTUNITY & INVESTMENT
Venture capital fund for investing in women-led businesses making a positive impact through greener and healthier technologies - true wealth.
Our impact shows that we will double your odds of success in the U.S. Entering any new market comes with a variety of opportunities and challenges for growth companies. Statistically, only one in five companies succeeds in expanding to the U.S. market. In 3 years, WorldUpstart has graduated 64 companies from 18 countries and 27 of them are now growing in the U.S. market with 8 FDA approvals.
We focus on advances in medical technology and digital health to change the face of healthcare.
Digitalis Ventures engineers solutions to unmet needs in health. Our deep technical financial and domain expertise enables us to drive solutions across venture investing technology development and public-interest problem-solving.
The tailored mentorship-focused programme is supported by content, events, workshops and webinars carefully curated to help impact startups flourish.
Investing in Early-Stage Companies Innovating at the Intersection of Biology and Technology.
